Icure Pharmaceutical Incorporation announced a private placement of unsecured privately placed convertible bonds with bearer interest for the gross proceeds of KRW 5,000,000,000 on July 7, 2023. The company will issue bonds through issuance of domestic privately placed convertible bonds. The transaction has been approved in the board of directors.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1,915 KRW | -0.36% | +1.06% | -8.37% |
1st Jan change | Capi. | |
---|---|---|
-8.37% | 51.99M | |
-3.33% | 249B | |
+10.09% | 18.86B | |
0.00% | 17.37B | |
-1.32% | 10.65B | |
-7.73% | 10.26B | |
+3.86% | 6.72B | |
+9.76% | 5.94B | |
-0.06% | 4.55B | |
-16.98% | 3.83B |
- Stock Market
- Equities
- A175250 Stock
- News Icure Pharmaceutical Incorporation
- Icure Pharmaceutical Incorporation announced that it expects to receive KRW 5 billion in funding